New Delhi, Sept. 18 -- The Delhi drugs control department on Wednesday directed manufacturers and marketers of pharmaceutical drugs and medical devices in Delhi to revise the maximum retail price (MRP) of their products, in line with the reduced Goods and Services Tax (GST) announced earlier this month. The department has asked them to review their MRP by September 22.
"All the manufacturers and marketer of drugs, formulations & medical devices located in the jurisdiction of Delhi are required to revise the MRP of drugs, formulations and medical devices as per revised GST rate w.e.f. 22.09.2025," a circular, a copy of which accessed by HT, said.htc
Published by HT Digital Content Services with permission from Hindustan Times....